SCN10A and colitis: Indeed, the targeted deletion of DOR in Nav1.8-expressing nociceptors prevents from the endogenous opioid-mediated analgesia at the latter phase of the DSS-induced colitis when T lymphocytes accumulate within the inflamed mucosa.